By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Normally when we interview top biopharma executives for feature articles, we’re looking for a unique story with personal insights about how they overcame some business challenge or implemented some business strategy. Recounting what an executive did while on sabbatical wouldn’t normally fit into that model. That is, unless that executive is Richard Bagger, J.D., EVP of corporate affairs and market access for Celgene.
And it all started at 4 a.m. — in Tokyo.